FDA staffer concerned about abortion pill prescription

The pro-life movement has recognized the danger of medication abortions that take place at home. Now, a top government spokesperson admits concern over the safety of chemical abortion prescriptions.

Less than a year ago, the Food and Drug Administration (FDA) granted approval for mifepristone, the first of two pills a pregnant woman takes to induce her abortion, to be prescribed during a virtual appointment. Even though physical examinations are impossible during these telehealth visits, the FDA has allowed such drugs to be mailed to pregnant women. The pills are approved only through 70 days of gestational age. 

However, some providers are now shipping the abortion pill to women who are not pregnant, a practice known as “advance provision.” It has grown in popularity since the Supreme Court overturned Roe vs. Wade in June, as providers try to convince women to have the drugs on hand, in case abortion law changes in their state as a result of the Dobbs decision. 

It was reported yesterday that an FDA rep spoke anonymously to Politico, saying, “The FDA is concerned about the advance prescribing of mifepristone for this use . . . Mifepristone is not approved for advance provision of a medical abortion.”

The site also reports that, “the FDA is concerned that if patients were to take mifepristone weeks or months after getting a prescription filled, a medical professional may not be able to assess if a pregnancy is intrauterine or ectopic or date pregnancies properly.”

Such an admission related to the abortion pill is rare. There’s no word yet on whether the FDA will revise its restrictions. We will keep you updated.


Myrna Maloney Flynn, MCFL President

PS - More than half of all abortions are now chemically induced. Did you know that Abortion Pill Reversal (APR) has successfully saved thousands of lives? Learn more about APR, (masscitizensforlife.org/abortion_pill_reversal) a pregnant woman’s “second chance at choice.”